Cell therapies

therapy in which cellular material is injected into a patient

Sipuleucel-T, sold under the brand name Provenge, developed by Dendreon Pharmaceuticals, LLC, is a cell-based cancer immunotherapy for prostate cancer (CaP). It is an autologous cellular immunotherapy.

use of stem cells to treat macular degeneration